References
- Armas, L.A., and Recker, R.R., 2012. Pathophysiology of osteoporosis: new mechanistic insights. Endocrinology and metabolism clinics of North America, 41 (3), 475–486.
- Aspray, T.J., and Hill, T.R., 2019. Osteoporosis and the ageing skeleton. Sub-cellular biochemistry, 91, 453–476.
- Goltzman, D., 2018. Functions of vitamin D in bone. Histochemistry and cell biology, 149 (4), 305–312.
- Harvey, N., Dennison, E., and Cooper, C., 2010. Osteoporosis: impact on health and economics. Nature reviews, 6 (2), 99–105.
- Haussler, M.R., et al., 2013. Molecular mechanisms of vitamin D action. Calcified tissue international, 92 (2), 77–98.
- Jia, F., et al., 2013. Vitamin D receptor BsmI polymorphism and osteoporosis risk: a meta-analysis from 26 studies. Genetic testing and molecular biomarkers, 17 (1), 30–34.
- Lane, N.E., 2006. Epidemiology, etiology, and diagnosis of osteoporosis. American journal of obstetrics and gynecology, 194 (2 Suppl), S3–S11.
- Mashhadiabbas, F., et al., 2018. Association of vitamin D receptor BsmI, TaqI, FokI, and ApaI polymorphisms with susceptibility of chronic periodontitis: a systematic review and meta-analysis based on 38 case -control studies. Dental research journal, 15 (3), 155–165.
- Moher, D., et al.,; PRISMA group. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine, 151 (4), 264–269.
- Qin, G., et al., 2013. Association of vitamin D receptor BsmI gene polymorphism with risk of osteoporosis: a meta-analysis of 41 studies. Molecular biology reports, 40 (1), 497–506.
- Sassi, F., Tamone, C., and D’Amelio, P., 2018. Vitamin D: nutrient, hormone, and immunomodulator. Nutrients, 10 (11), 1656.
- Sidlauskas, K.M., Sutton, E.E., and Biddle, M.A., 2014. Osteoporosis in men: epidemiology and treatment with denosumab. Clinical interventions in aging, 9, 593–601.
- Stang, A., 2010. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European journal of epidemiology, 25 (9), 603–605.
- Thambiah, S.C., and Yeap, S.S., 2020. Osteoporosis in South-East Asian countries. The clinical biochemist reviews, 41 (1), 29–40.
- Uitterlinden, A.G., et al., 2004. Genetics and biology of vitamin D receptor polymorphisms. Gene, 338 (2), 143–156.
- Valdivielso, J.M., and Fernandez, E., 2006. Vitamin D receptor polymorphisms and diseases. Clinica Chimica Acta, 371 (1-2), 1–12.
- Wimalawansa, S.J., 2019. Vitamin D deficiency: effects on oxidative stress, epigenetics, gene regulation, and aging. Biology ( Biology), 8 (2), 30.
- Zhang, J.Z., et al., 2018. Vitamin D receptor gene polymorphism, serum 25-hydroxyvitamin D levels, and risk of vitiligo: a meta-analysis. Medicine, 97 (29), e11506.
- Zhang, L., et al., 2018. Associations between VDR gene polymorphisms and osteoporosis risk and bone mineral density in postmenopausal women: a systematic review and meta-analysis. Scientific reports, 8 (1), 981.
- Zhang, Y.J., et al., 2018. Association between VDR polymorphisms and multiple sclerosis: systematic review and updated meta-analysis of case-control studies. Neurological sciences, 39 (2), 225–234.
- Zintzaras, E., et al., 2006. ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and the risk of osteoporosis: a meta-analysis. Disease markers, 22 (5-6), 317–326.